Earth Science Tech, Inc. (OTCQB: ETST) announced that it has started work on the formulation of a full-spectrum CBD beverage. The biotech company that focuses on CBD, pharmaceutical and nutraceutical products will be utilizing its University of Central Oklahoma Provisional Patent to develop the formulation, aimed at enhancing immune system function (http://cnw.fm/i3fbW).
The High Grade Full Spectrum Cannabinoids beverage is the result of positive results derived from clinical trials in 2015 run jointly with the University of Central Oklahoma. The studies focused on the positive effects CBD can have on strengthening immune response.
Currently, Earth Science Tech is putting effort in the development of the right beverage formula and in the selection of a bottling option.
According to Earth Science Tech CEO and CSO Michael Aube, the beverage taps into the immune-stimulating, antioxidant and anti-psychotic effects of CBD. It has the exact opposite effect to THC, which is psychoactive and addictive.
“At Earth Science Tech we focused on full spectrum cannabinoids derived from industrial hemp that contains extremely low to no THC since THC is psychoactive causing dependency and mental illness in young individuals,” Aube said in a news release. “This means that all our products are beneficial for recreational marijuana consumers because it helps them to balance their intake of psychoactive and anti-psychotic cannabinoids. Our cannabinoid products help counter the side effects of THC in addition of having itself other interesting biological activities like anti-inflammatory and antioxidant properties.”
The World Health Organization (WHO) confirms the wide array of CBD benefits. After reviewing numerous studies, WHO’s Expert Committee on Drug Dependence concluded that CBD does not have effects indicative of abuse potential (http://cnw.fm/fOp80). In addition, it could be a suitable treatment for epilepsy, depression, anxiety, Parkinson’s disease and Alzheimer’s disease. Its well-established anti-inflammatory properties could contribute to several additional health advantages.
Forecasts suggest that the CBD beverages market could reach $260 million by 2022 (http://cnw.fm/e0etU). This is one of the reasons why numerous large beverage manufacturers are currently looking into opportunities to begin the development of drinks that feature CBD as one of the main ingredients.
The overall CBD market is on the road to rapid expansion, as well. Hemp-derived CBD sales are expected to reach $591 million this year and may grow exponentially, to $22 billion by 2022, if the 2018 Farm Bill passes, according to Brightfield Group research cited by Cannabis Business Times (http://cnw.fm/D4e4Y). The 2018 Farm Bill would remove hemp from the Controlled Substances Act, which would allow CBD to be legally sold in all states.
The cannabis beverages market is still in the initial stages of development, ETST President, Director and Chairman Nickolas S. Tabraue noted in a news release. With forecasts for exponential growth, Earth Science Tech is positioned for success in the years to come.
Earth Science Tech is a Florida-based biotechnology company that focuses on cannabis, CBD research, product development and the creation of medical devices. Currently, the company offers high purity full spectrum CBD oil. Through its partnership with the University of Central Oklahoma, the company has established the immune stimulating effects of CBD, as well as its potential for the provision of positive results in breast cancer cases.
For more information, visit the company’s website at www.EarthScienceTech.com
More from PsychedelicNewsWire
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) PsychedelicNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…
The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…
Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…
Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…
NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…
Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…